SCI Abstract

search
+
Chimerism analysis by ABO blood group genotyping with digital droplet PCR
Chimerism analysis by ABO blood group genotyping with digital droplet PCR
Chimerism analysis is an important post-transplant assessment for allogeneic hematopoietic stem cell transplant (HCT) reci...
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications
In 2024, the World Health Organization (WHO) launched a new classification of lymphoid neoplasms, a revision of the previo...
Graft CD8+ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies
Graft CD8+ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies
T cell-replete haploidentical hematopoietic stem cell transplantation (TCR-haplo-HSCT) is a potentially curative therapy f...
Pseudo-Chediak–Higashi inclusions and Auer rods in a case of therapy-related acute monocytic leukemia
Pseudo-Chediak–Higashi inclusions and Auer rods in a case of therapy-related acute monocytic leukemia
Conflict of interest The author has no conflict of interest...
A 25-year clonal resurrection in adult T-cell leukemia-lymphoma relapse
A 25-year clonal resurrection in adult T-cell leukemia-lymphoma relapse
Here, we report a rare case of relapsed adult T-cell leukemia-lymphoma (ATL) with evidence of clonal relapse 26 y...
Recent advances in understanding the biology of follicular lymphoma
Recent advances in understanding the biology of follicular lymphoma
Follicular lymphoma (FL), the most common indolent B-cell lymphoma, develops over decades before manifesting as overt dise...
JSH practical guidelines for hematological malignancies, 2023: leukemia-6. Myelodysplastic syndromes (MDS)
JSH practical guidelines for hematological malignancies, 2023: leukemia-6. Myelodysplastic syndromes (MDS)
Conflict of interest YM has received per diem, including sp...
Temporal changes in corticosteroid dose during ibrutinib treatment in patients with cGVHD and pulmonary involvement
Temporal changes in corticosteroid dose during ibrutinib treatment in patients with cGVHD and pulmonary involvement
The GVH3001 study assessed the efficacy and safety of ibrutinib in Japanese patients with steroid-dependent or -refractory...
Understanding the intrinsic biology of diffuse large B-cell lymphoma: recent advances and future prospects
Understanding the intrinsic biology of diffuse large B-cell lymphoma: recent advances and future prospects
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoid tumor, and accounts for approximately 30–4...
Successful treatment of type I cryoglobulinemia with a combination of carfilzomib, cyclophosphamide, and dexamethasone: a case report and literature review
Successful treatment of type I cryoglobulinemia with a combination of carfilzomib, cyclophosphamide, and dexamethasone: a case report and literature review
Type I cryoglobulinemia is typically associated with hematological malignancies such as B-cell lymphomas and plasma cell n...
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a life-threatening complicat...
Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia
Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia
Fostamatinib had superior efficacy to a placebo and acceptable safety profiles for at least 1 year in a phase 3 study of J...
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02
HM-SCREEN-Japan is a multicenter collaborative project in Japan to evaluate the clinical utility of a cancer genome panel ...
Current treatment approach and future perspectives in B cell lymphoma
Current treatment approach and future perspectives in B cell lymphoma
Diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) represent the two major subtypes of mature B cell lymph...
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Response and progression criteria are necessary for any malignancy to standa...
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
Accumulating evidence suggests that blinatumomab (a CD3-CD19 bispecific T-ce...
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases
Anemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
Despite the considerable effort to characterize the genomic landscape of chronic lymphocytic leukemia (CLL), published dat...
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Patients with relapsed/refractory multiple myeloma (RRMM) have a poor prognosis and a need remains for novel effective the...
Defining ‘Intention’ in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4....
Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
CBF-AMLs, which account for approximately 12–15% of all AML cases, involve c...
Correction: A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4....
Investigations on the Hemostatic Potential of Physiological Body Fluids
Thieme E-Books & E-Journals
Update on Tissue Factor Detection in Blood in 2024: A Narrative Review
Thieme E-Books & E-Journals
Komplementdysregulation als Biomarker für Post Covid
Thieme E-Books & E-Journals
iTTP in der Schwangerschaft: Erfolgreiche Behandlung mit Caplacizumab
Thieme E-Books & E-Journals
Be Curious. Try New Things
Thieme E-Books & E-Journals
Management of Adult Patients with Newly Diagnosed or Relapsed Primary Immune Thrombocytopenia in Eastern Austria
Thieme E-Books & E-Journals
Treatment of Cancer-Associated Thrombosis: An Update
Thieme E-Books & E-Journals
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Thieme E-Books & E-Journals
Load More
format_indent_increase